Calling all coronavirus researchers: keep sharing, stay open.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Structural under-reporting of informed consent, data handling and sharing, ethical approval, and application of Open Science principles as proxies for study quality conduct in COVID-19 research: a systematic scoping review.BMJ global health · 2023
   Article
2. Systems Vaccinology in HIV Vaccine Development.Vaccines · 2022
   Article
3. Evolution of scientific collaboration on COVID-19: A bibliometric analysis.Learned publishing : journal of the Association of Learned and Professional Society Publishers · 2021
   Article
4. The Challenges and Successes of Dealing with the COVID-19 Pandemic in India.Research and reports in tropical medicine · 2021
   Review
5. The sharing of research data facing the COVID-19 pandemic.Scientometrics · 2021
   Article
6. When science goes viral: The research response during three months of the COVID-19 outbreak.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020
   Article
7. Following data as it crosses borders during the COVID-19 pandemic.Journal of the American Medical Informatics Association : JAMIA · 2020
   Article
8. Statistical Explorations and Univariate Timeseries Analysis on COVID-19 Datasets to Understand the Trend of Disease Spreading and Death.Sensors (Basel, Switzerland) · 2020
   Article
9. Computational Models Identify Several FDA Approved or Experimental Drugs as Putative Agents Against SARS-CoV-2.ChemRxiv : the preprint server for chemistry · 2020
   Article
10. COVID-19 Therapeutic and Prevention.International journal of antimicrobial agents · 2020
    Article
11. [Ethical issues related to Coronavirus epidemic].Revista medica de Chile · 2020
    Article
12. Antivirals for COVID-19: A critical review.Clinical epidemiology and global health
    Review

Corrections and comments

• Comment on
  A pneumonia outbreak associated with a new coronavirus of probable bat origin.2020
• Comment on
  A new coronavirus associated with human respiratory disease in China.2020

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as